Erectile dysfunction and hypertension
- PMID: 17151696
- DOI: 10.1038/sj.ijir.3901527
Erectile dysfunction and hypertension
Abstract
Recent analyses suggest that about 67-68% of men with hypertension have some degree of erectile dysfunction (ED). With about 25 million men in the US with hypertension, substantial numbers of hypertension-related ED exist that tend to be of a more severe nature than the general population. Men with ED are also more likely to have hypertension. Thiazide diuretic and beta-blocker therapy may contribute to ED. Phosphodiesterase-5 (PDE5) inhibitors are effective therapy in men with ED owing to hypertension who are taking antihypertensive medicines including those on multiple antihypertensive medicines. The addition of PDE5 inhibitors to usual common antihypertensive medicines (diuretics, beta blockers, calcium blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers) results in either no or small additive reductions in blood pressure (BP) and no increase in serious clinical adverse events. There are however precautions regarding the use of PDE5 inhibitors in patients taking alpha blockers for either hypertension or benign prostatic hypertrophy, as some patients may develop orthostatic hypotension. Organic nitrates remain an absolute contraindication for PDE5 inhibitors because synergistic and symptomatic reductions in BP may occur in some patients with this drug combination.
Similar articles
-
Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.Am J Cardiol. 2005 Dec 26;96(12B):42M-46M. doi: 10.1016/j.amjcard.2005.07.011. Epub 2005 Dec 5. Am J Cardiol. 2005. PMID: 16387566 Review.
-
[Interaction between sildenafil and antihypertensive drugs: what is evidence-based?].Dtsch Med Wochenschr. 2001 Oct 12;126(41):1144-9. doi: 10.1055/s-2001-17743. Dtsch Med Wochenschr. 2001. PMID: 11595959 Review. German.
-
Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients.Int J Impot Res. 2003 Oct;15(5):314-7. doi: 10.1038/sj.ijir.3901041. Int J Impot Res. 2003. PMID: 14562130
-
Erectile dysfunction in patients with coronary artery disease.Int J Impot Res. 2005 May-Jun;17(3):209-15. doi: 10.1038/sj.ijir.3901309. Int J Impot Res. 2005. PMID: 15729374 Review.
-
Cardiovascular drug use and the incidence of erectile dysfunction.Int J Impot Res. 2007 Mar-Apr;19(2):208-12. doi: 10.1038/sj.ijir.3901516. Epub 2006 Aug 10. Int J Impot Res. 2007. PMID: 16900205
Cited by
-
A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study.BMJ. 2023 Dec 12;383:e076197. doi: 10.1136/bmj-2023-076197. BMJ. 2023. PMID: 38086555 Free PMC article.
-
Quality of life of hypertensive men with erectile dysfunction in a tertiary health centre in southern Nigeria.Afr J Prim Health Care Fam Med. 2023 Apr 26;15(1):e1-e7. doi: 10.4102/phcfm.v15i1.3875. Afr J Prim Health Care Fam Med. 2023. PMID: 37132563 Free PMC article.
-
Analysis of integrated clinical safety data of tadalafil in patients receiving concomitant antihypertensive medications.J Clin Hypertens (Greenwich). 2022 Feb;24(2):167-178. doi: 10.1111/jch.14435. Epub 2022 Jan 31. J Clin Hypertens (Greenwich). 2022. PMID: 35099113 Free PMC article.
-
Wearable E-Textile and CNT Sensor Wireless Measurement System for Real-Time Penile Erection Monitoring.Sensors (Basel). 2021 Dec 29;22(1):231. doi: 10.3390/s22010231. Sensors (Basel). 2021. PMID: 35009773 Free PMC article.
-
The Role and Efficacy of Coenzyme Q10 in the Management of Erectile Dysfunction in a Hypertensive Male: An Interventional Study.Cureus. 2021 Sep 13;13(9):e17937. doi: 10.7759/cureus.17937. eCollection 2021 Sep. Cureus. 2021. PMID: 34660127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
